Videos
Understanding Indications, Tailoring Therapy Options for CLL Patients
05/18/2020
Benyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment for patients with CLL.
Subscribe and Stay Ahead With Daily Industry Insights
First Report Managed Care Newsletter